ArticleThe Journal of clinical investigation2017

Cell-penetrating peptides selectively targeting SMAD3 inhibit profibrotic TGF-β signaling.

Jeong-Han Kang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.